EzriCare Artificial Tears Eye Drops Recalled for Bacterial Contamination
EzriCare Artificial Tears eye drops are being recalled nationwide due to bacterial contamination found in unopened bottles. The FDA identified non-sterile products that could pose a risk to eye health.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum score of 4. The recall involves confirmed bacterial contamination in unopened eye-drop products, which pose a direct risk to sensitive eye tissue, though no illnesses have been reported.
Plain-English summary
EzriCare Artificial Tears Lubricant Eye Drops (10 MG in 1 ml, 15 ml bottles) are being recalled because FDA testing found bacterial contamination in unopened products. The affected product was distributed nationwide in the United States.
The recalled product includes multiple lot numbers: PCMI005 (expiring August 2024) and lot numbers PCMJ001, PCMJ002, PCMJ004, PCMJ005, PCMJ006, PCMJ008, PCMJ009, PCMJ010, PCMJ011, PCMJ012, PCMJ013, PCMJ014, and PCMJ015 (expiring March 2025). A total of 400,008 bottles were distributed through two distributors who further distributed the product nationwide.
Consumers who have purchased these eye drops should stop using them immediately and discard them safely. While no illnesses have been reported to date, applying contaminated eye drops could introduce bacteria to the eye and potentially cause infection or other adverse effects. Consult a healthcare provider if you have used this product and experience any eye problems.
The recalled product
- Product
- Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.
- Manufacturer
- Global Pharma Healthcare Private Limited
- Category
- Drug — Lubricant Eye Drops
- Hazard
- bacterial-contamination
- non-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Lot #: PCMI005
- Exp. date AUG-2024
- PCMJ001
- PCMJ002
- PCMJ004
- PCMJ005
- PCMJ006
- PCMJ008
- PCMJ009
- PCMJ010
- PCMJ011
- PCMJ012
- PCMJ013
- PCMJ014
- PCMJ015
- Exp. date MAR-2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27